Publications found:
55,654
Sort by:
Axillary Hyperhidrosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF AXILLARY HYPERHIDROSIS PIPELINE REPORT INCLUDES Panorama of Axillary Hyperhidrosis pipeline markets including statistics on therapeutic drugs and companies involved Axillary Hyperhidrosis Pipeline candidates across various development ...
August 2018
40 pages
B Cell Chronic Lymphocytic Leukemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA PIPELINE REPORT INCLUDES Panorama of B Cell Chronic Lymphocytic Leukemia pipeline markets including statistics on therapeutic drugs and companies involved B Cell Chronic Lymphocytic Leukemia Pipeline candidates across ...
August 2018
130 pages
Bacillary Dysentery (Shigellosis) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BACILLARY DYSENTERY (SHIGELLOSIS) PIPELINE REPORT INCLUDES Panorama of Bacillary Dysentery (Shigellosis) pipeline markets including statistics on therapeutic drugs and companies involved Bacillary Dysentery (Shigellosis) Pipeline candidates across various development ...
August 2018
30 pages
Bacterial Conjunctivitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BACTERIAL CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Bacterial Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Bacterial Conjunctivitis Pipeline candidates across various development ...
August 2018
20 pages
Bacterial Vaginosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BACTERIAL VAGINOSIS PIPELINE REPORT INCLUDES Panorama of Bacterial Vaginosis pipeline markets including statistics on therapeutic drugs and companies involved Bacterial Vaginosis Pipeline candidates across various development ...
August 2018
40 pages
Basal Cell Epithelioma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BASAL CELL EPITHELIOMA PIPELINE REPORT INCLUDES Panorama of Basal Cell Epithelioma pipeline markets including statistics on therapeutic drugs and companies involved Basal Cell Epithelioma Pipeline candidates across various development ...
August 2018
140 pages
Batten Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BATTEN DISEASE PIPELINE REPORT INCLUDES Panorama of Batten Disease pipeline markets including statistics on therapeutic drugs and companies involved Batten Disease Pipeline candidates across various development ...
August 2018
40 pages
Becker Muscular Dystrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BECKER MUSCULAR DYSTROPHY PIPELINE REPORT INCLUDES Panorama of Becker Muscular Dystrophy pipeline markets including statistics on therapeutic drugs and companies involved Becker Muscular Dystrophy Pipeline candidates across various development ...
August 2018
40 pages
Behcet Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BEHCET DISEASE PIPELINE REPORT INCLUDES Panorama of Behcet Disease pipeline markets including statistics on therapeutic drugs and companies involved Behcet Disease Pipeline candidates across various development ...
August 2018
50 pages
Benign Prostatic Hyperplasia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BENIGN PROSTATIC HYPERPLASIA PIPELINE REPORT INCLUDES Panorama of Benign Prostatic Hyperplasia pipeline markets including statistics on therapeutic drugs and companies involved Benign Prostatic Hyperplasia Pipeline candidates across various development ...
August 2018
90 pages
Binge Eating Disorder R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BINGE EATING DISORDER PIPELINE REPORT INCLUDES Panorama of Binge Eating Disorder pipeline markets including statistics on therapeutic drugs and companies involved Binge Eating Disorder Pipeline candidates across various development ...
August 2018
40 pages
Birch Pollen Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BIRCH POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Birch Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Birch Pollen Allergy Pipeline candidates across various development ...
August 2018
30 pages
Blepharitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF BLEPHARITIS PIPELINE REPORT INCLUDES Panorama of Blepharitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Bone Fracture R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BONE FRACTURE PIPELINE REPORT INCLUDES Panorama of Bone Fracture pipeline markets including statistics on therapeutic drugs and companies involved Bone Fracture Pipeline candidates across various development ...
August 2018
80 pages
Bone Metastasis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BONE METASTASIS PIPELINE REPORT INCLUDES Panorama of Bone Metastasis pipeline markets including statistics on therapeutic drugs and companies involved Bone Metastasis Pipeline candidates across various development ...
August 2018
80 pages
Botulism R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF BOTULISM PIPELINE REPORT INCLUDES Panorama of Botulism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Brain Edema R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BRAIN EDEMA PIPELINE REPORT INCLUDES Panorama of Brain Edema pipeline markets including statistics on therapeutic drugs and companies involved Brain Edema Pipeline candidates across various development ...
August 2018
30 pages
Brain Hemorrhage R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BRAIN HEMORRHAGE PIPELINE REPORT INCLUDES Panorama of Brain Hemorrhage pipeline markets including statistics on therapeutic drugs and companies involved Brain Hemorrhage Pipeline candidates across various development ...
August 2018
40 pages
Brain Ischemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BRAIN ISCHEMIA PIPELINE REPORT INCLUDES Panorama of Brain Ischemia pipeline markets including statistics on therapeutic drugs and companies involved Brain Ischemia Pipeline candidates across various development ...
August 2018
40 pages
Bronchiectasis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF BRONCHIECTASIS PIPELINE REPORT INCLUDES Panorama of Bronchiectasis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Bronchitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF BRONCHITIS PIPELINE REPORT INCLUDES Panorama of Bronchitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Bronchopulmonary Dysplasia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BRONCHOPULMONARY DYSPLASIA PIPELINE REPORT INCLUDES Panorama of Bronchopulmonary Dysplasia pipeline markets including statistics on therapeutic drugs and companies involved Bronchopulmonary Dysplasia Pipeline candidates across various development ...
August 2018
50 pages
Bullous Pemphigoid R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BULLOUS PEMPHIGOID PIPELINE REPORT INCLUDES Panorama of Bullous Pemphigoid pipeline markets including statistics on therapeutic drugs and companies involved Bullous Pemphigoid Pipeline candidates across various development ...
August 2018
50 pages
Burkholderia Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BURKHOLDERIA INFECTIONS PIPELINE REPORT INCLUDES Panorama of Burkholderia Infections pipeline markets including statistics on therapeutic drugs and companies involved Burkholderia Infections Pipeline candidates across various development ...
August 2018
60 pages
Burkitt Lymphoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF BURKITT LYMPHOMA PIPELINE REPORT INCLUDES Panorama of Burkitt Lymphoma pipeline markets including statistics on therapeutic drugs and companies involved Burkitt Lymphoma Pipeline candidates across various development ...
August 2018
100 pages
Burns R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF BURNS PIPELINE REPORT INCLUDES Panorama of Burns pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Cachexia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CACHEXIA PIPELINE REPORT INCLUDES Panorama of Cachexia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Canavan Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CANAVAN DISEASE PIPELINE REPORT INCLUDES Panorama of Canavan Disease pipeline markets including statistics on therapeutic drugs and companies involved Canavan Disease Pipeline candidates across various development ...
August 2018
20 pages
Cancer Anorexia Cachexia Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF CANCER ANOREXIA CACHEXIA SYNDROME PIPELINE REPORT INCLUDES Panorama of Cancer Anorexia Cachexia Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Cancer Anorexia Cachexia Syndrome Pipeline candidates across ...
August 2018
90 pages
Cancer Pain R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CANCER PAIN PIPELINE REPORT INCLUDES Panorama of Cancer Pain pipeline markets including statistics on therapeutic drugs and companies involved Cancer Pain Pipeline candidates across various development ...
August 2018
100 pages
Candidiasis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CANDIDIASIS PIPELINE REPORT INCLUDES Panorama of Candidiasis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
140 pages
Cat Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CAT ALLERGY PIPELINE REPORT INCLUDES Panorama of Cat Allergy pipeline markets including statistics on therapeutic drugs and companies involved Cat Allergy Pipeline candidates across various development ...
August 2018
20 pages
Cataract R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CATARACT PIPELINE REPORT INCLUDES Panorama of Cataract pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Cedar Pollen Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CEDAR POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Cedar Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Cedar Pollen Allergy Pipeline candidates across various development ...
August 2018
30 pages
Celiac Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CELIAC DISEASE PIPELINE REPORT INCLUDES Panorama of Celiac Disease pipeline markets including statistics on therapeutic drugs and companies involved Celiac Disease Pipeline candidates across various development ...
August 2018
70 pages
Cerebral Malaria R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CEREBRAL MALARIA PIPELINE REPORT INCLUDES Panorama of Cerebral Malaria pipeline markets including statistics on therapeutic drugs and companies involved Cerebral Malaria Pipeline candidates across various development ...
August 2018
30 pages
Cerebral Palsy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CEREBRAL PALSY PIPELINE REPORT INCLUDES Panorama of Cerebral Palsy pipeline markets including statistics on therapeutic drugs and companies involved Cerebral Palsy Pipeline candidates across various development ...
August 2018
30 pages
Cervical Intraepithelial Neoplasia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CERVICAL INTRAEPITHELIAL NEOPLASIA PIPELINE REPORT INCLUDES Panorama of Cervical Intraepithelial Neoplasia pipeline markets including statistics on therapeutic drugs and companies involved Cervical Intraepithelial Neoplasia Pipeline candidates across various development ...
August 2018
80 pages
Chagas Disease (American Trypanosomiasis) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF CHAGAS DISEASE (AMERICAN TRYPANOSOMIASIS) PIPELINE REPORT INCLUDES Panorama of Chagas Disease (American Trypanosomiasis) pipeline markets including statistics on therapeutic drugs and companies involved Chagas Disease (American Trypanosomiasis) Pipeline candidates across ...
August 2018
70 pages
Charcot Marie Tooth Disease (Type I A) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CHARCOT MARIE TOOTH DISEASE (TYPE I A) PIPELINE REPORT INCLUDES Panorama of Charcot Marie Tooth Disease (Type I A) pipeline markets including statistics on therapeutic drugs and companies involved Charcot Marie Tooth Disease (Type I A) Pipeline candidates ...
August 2018
40 pages
Charcot Marie Tooth Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF CHARCOT MARIE TOOTH DISEASE PIPELINE REPORT INCLUDES Panorama of Charcot Marie Tooth Disease pipeline markets including statistics on therapeutic drugs and companies involved Charcot Marie Tooth Disease Pipeline candidates across ...
August 2018
50 pages
Chemotherapy Induced Anemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CHEMOTHERAPY INDUCED ANEMIA PIPELINE REPORT INCLUDES Panorama of Chemotherapy Induced Anemia pipeline markets including statistics on therapeutic drugs and companies involved Chemotherapy Induced Anemia Pipeline candidates across various development ...
August 2018
40 pages
Chemotherapy Induced Neutropenia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CHEMOTHERAPY INDUCED NEUTROPENIA PIPELINE REPORT INCLUDES Panorama of Chemotherapy Induced Neutropenia pipeline markets including statistics on therapeutic drugs and companies involved Chemotherapy Induced Neutropenia Pipeline candidates across various development ...
August 2018
90 pages
Chemotherapy Induced Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Chemotherapy Induced Peripheral Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Chemotherapy Induced Peripheral Neuropathy Pipeline candidates across ...
August 2018
100 pages
Chikungunya Fever R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CHIKUNGUNYA FEVER PIPELINE REPORT INCLUDES Panorama of Chikungunya Fever pipeline markets including statistics on therapeutic drugs and companies involved Chikungunya Fever Pipeline candidates across various development ...
August 2018
80 pages
Chlamydia Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CHLAMYDIA INFECTIONS PIPELINE REPORT INCLUDES Panorama of Chlamydia Infections pipeline markets including statistics on therapeutic drugs and companies involved Chlamydia Infections Pipeline candidates across various development ...
August 2018
60 pages
Cholera R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CHOLERA PIPELINE REPORT INCLUDES Panorama of Cholera pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Chondrosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF CHONDROSARCOMA PIPELINE REPORT INCLUDES Panorama of Chondrosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
220 pages
Choroidal Neovascularization R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF CHOROIDAL NEOVASCULARIZATION PIPELINE REPORT INCLUDES Panorama of Choroidal Neovascularization pipeline markets including statistics on therapeutic drugs and companies involved Choroidal Neovascularization Pipeline candidates across various development ...
August 2018
40 pages
